A randomised clinical trial found that pressure-mediated biofeedback improves postpartum stress urinary incontinence.
This technology initially targets mixed urinary incontinence, with the potential for future applications of the MintNeuro chipset in conditions such as Parkinson's disease, dementia, and depression.